Conditions

Rheumatoid Arthritis stands as a challenging autoimmune disorder. This condition involves the immune system mistakenly targeting the synovium—the lining around joints—leading to inflammation, pain, stiffness, and potential joint damage over time. Unlike Osteoarthritis, which often associates with wear and tear, Rheumatoid Arthritis has a more intricate origin involving an overactive immune response.

Exploring Innovative Approaches

In the pursuit of effective solutions, innovative medical therapies present promising avenues for addressing the complexities of Rheumatoid Arthritis. Among these, MSC therapy emerges as a transformative option. MSC therapy offers a revolutionary approach by harnessing the ability of these cells to suppress the overactive immune response, thereby reducing inflammation and preventing further harm to the joints.

Clinical Progress and Promising Outcomes

Studies show excellent results after the application of MSCs in Rheumatoid Arthritis patient. These patients report a significant decrease in inflammation, improved joint function, and a reduction in pain levels. This non-invasive treatment option not only addresses the symptoms but also aims to modulate the immune system, presenting a holistic approach to managing this autoimmune condition.

Protocol

Direct injection of cord tissue-derived Mesenchymal Stem Cells into the affected joint. This minimally invasive procedure takes approximately 45 minutes, with minimal downtime. Patients typically return home just two days following their scheduled appointment.